We are live on ! Find out more
MHC

Meyer Handelman Company Portfolio holdings

AUM $3.22B
1-Year Est. Return 24.51%
This Fund
S&P 500
This Quarter Est. Return
+0.29%
1 Year Est. Return
+24.51%
3 Year Est. Return
+68.19%
5 Year Est. Return
+95.69%
10 Year Est. Return
+272.81%
AUM
$2.21B
AUM Growth
-$15.8M
Cap. Flow
-$6.57M
Cap. Flow %
-0.3%
Top 10 Hldgs %
28.26%
Holding
211
New
12
Increased
36
Reduced
53
Closed
2

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$21.3M
2
SLB icon
SLB Ltd
SLB
+$1.57M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.2M
4
FCX icon
Freeport-McMoran
FCX
+$830K
5
MSFT icon
Microsoft
MSFT
+$815K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$29.7M
2
PFE icon
Pfizer
PFE
+$1.41M
3
MCK icon
McKesson
MCK
+$1.05M
4
PPG icon
PPG Industries
PPG
+$984K
5
ALLE icon
Allegion
ALLE
+$823K

Sector Composition

Rank Sector Weight
1 Healthcare 18.54%
2 Consumer Staples 17.43%
3 Industrials 17.15%
4 Technology 12.31%
5 Energy 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$343B
$75.6M 3.42%
922,935
-850
-0.1% -$73.1K
HON icon
2
Honeywell
HON
$77.1B
$74.5M 3.37%
795,132
-5,272
-0.7% -$482K
GE icon
3
GE Aerospace
GE
$367B
$70.3M 3.18%
591,173
-667
-0.1% -$79.4K
IBM icon
4
IBM
IBM
$202B
$67.6M 3.06%
440,810
-1,811
-0.4% -$275K
PFE icon
5
Pfizer
PFE
$140B
$66M 2.99%
1,998,826
-44,218
-2% -$1.41M
KMB icon
6
Kimberly-Clark
KMB
$36.4B
$63.4M 2.87%
592,335
-3,650
-0.6% -$403K
BMY icon
7
Bristol-Myers Squibb
BMY
$127B
$54.5M 2.46%
844,233
-5,530
-0.7% -$346K
MCK icon
8
McKesson
MCK
$98.5B
$54M 2.44%
238,717
-4,750
-2% -$1.05M
XOM icon
9
ExxonMobil
XOM
$651B
$53.5M 2.42%
629,067
-350
-0.1% -$31K
MMM icon
10
3M
MMM
$89B
$45.2M 2.04%
327,631
-2,631
-0.8% -$362K
VZ icon
11
Verizon
VZ
$194B
$44.4M 2.01%
912,576
+5,600
+0.6% +$270K
DD
12
DELISTED
Du Pont De Nemours E I
DD
$40.6M 1.84%
598,131
-3,370
-0.6% -$240K
PEP icon
13
PepsiCo
PEP
$186B
$38.9M 1.76%
407,020
-1,400
-0.3% -$135K
CVX icon
14
Chevron
CVX
$388B
$36.7M 1.66%
349,939
+1,400
+0.4% +$149K
GILD icon
15
Gilead Sciences
GILD
$161B
$34.6M 1.57%
352,600
MSFT icon
16
Microsoft
MSFT
$2.84T
$34.4M 1.56%
847,048
+18,718
+2% +$815K
MRK icon
17
Merck
MRK
$324B
$33.6M 1.52%
612,987
PPG icon
18
PPG Industries
PPG
$25.9B
$31.8M 1.44%
281,712
-8,588
-3% -$984K
TT icon
19
Trane Technologies
TT
$106B
$30.3M 1.37%
444,900
-11,600
-3% -$766K
SYY icon
20
Sysco
SYY
$39.7B
$29.8M 1.35%
789,532
-2,800
-0.4% -$110K
TXN icon
21
Texas Instruments
TXN
$255B
$28.4M 1.29%
496,900
-100
-0% -$5.62K
AMGN icon
22
Amgen
AMGN
$203B
$27.7M 1.26%
173,523
WMT icon
23
Walmart Inc
WMT
$871B
$26.9M 1.22%
980,748
+4,950
+0.5% +$140K
RTX icon
24
RTX Corp
RTX
$287B
$26.5M 1.2%
359,193
-318
-0.1% -$23.8K
MPC icon
25
Marathon Petroleum
MPC
$90.3B
$26.4M 1.19%
515,326

Similar funds

Meyer Handelman Company's Q1 2015 Portfolio in Review

As of Q1 2015, Meyer Handelman Company held 211 positions worth $2.21B, down 0.71% from $2.23B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Meyer Handelman Company's Q1 2015 filing shows 12 new, 36 increased, 53 reduced and 2 closed positions. Its largest new stake was Medtronic: 280,828 shares worth $21.9M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $29.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Industrials.

  • Meyer Handelman Company's largest Q1 2015 buy was Medtronic: 280,828 shares worth $21.9M.
  • Meyer Handelman Company added most to SLB Ltd in Q1 2015, an estimated $1.57M increase.
  • Meyer Handelman Company's biggest Q1 2015 reduction was Pfizer, cutting an estimated $1.41M.
  • Meyer Handelman Company fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $29.7M.
  • Meyer Handelman Company's ten largest holdings make up 28% of its $2.21B portfolio in Q1 2015.
  • Meyer Handelman Company opened 12 new positions and closed 2 in Q1 2015.
  • Meyer Handelman Company's portfolio value fell 0.71% quarter-over-quarter to $2.21B.

Based on Meyer Handelman Company's 13F filing for Q1 2015, filed 27 Apr 2015.